Drug Trial Radar · NCT00236015
A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
Last checked: Nov 19, 2026Latest source record: May 9, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
880
Actual
Start
Nov 2004
Primary completion
Not stated
Study completion Mar 2006
Sponsor
- Lead sponsor
- CephalonIndustry
- Sponsor type
- Industry
- First posted
- Oct 12, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder (GAD).
Conditions
- Anxiety Disorder
Interventions
GabitrilDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduction of symptomatology associated with Generalized Anxiety Disorder as assessed by the change from baseline to end point in the total score of the HAM-A scale.
Locations
54 sites in 2 countries. Site status is shown where the registry gives one.
Pivotol Research Centers
Mesa, Arizona
Pivotal Research Center
Peoria, Arizona
Valley Clinical Research
El Centro, California
Radiant Research Irvine
Irvine, California
Pharmacology Research Institute
Los Alamitos, California
Pharmacology Research Institute
Riverside, California
Clinical Innovations, Inc.
Santa Ana, California
Radiant Research
Denver, Colorado
University of Connecticut Health Center
Farmington, Connecticut
Miami Research Associates
Miami, Florida
Medical Research Group of Central Florida
Orange City, Florida
Clinical Neuroscience Solutions, Inc.
Orlando, Florida
Roskamp Institute, Clinical Trials Division
Sarasota, Florida
Stedman Clinical Trials
Tampa, Florida
Emory University
Atlanta, Georgia
American Medical Research
Aurora, Illinois
Henry Lahmeyer MD & Associates
Northfield, Illinois
Midwest Center for Neurobehavioral Medicine
Oakbrook Terrace, Illinois
Indiana University Hospital AOC
Indianapolis, Indiana
Vince & Associates Clinical Research
Overland Park, Kansas
Pedia Research, LLC
Owensboro, Kentucky
Four Rivers Clinical Research
Paducah, Kentucky
LSU Health Science Center
Shreveport, Louisiana
Capital Clinical Research Associates
Rockville, Maryland
Dupont Clinical Research
Rockville, Maryland
Center for Psychopharmacologic Research and Treatment
Worcester, Massachusetts
Wayne State University
Detroit, Michigan
Regions Hospital - Department of Behavioral Health
Saint Paul, Minnesota
Radiant Research
Las Vegas, Nevada
Center for Emotional Fitness
Moorestown, New Jersey
Fieve Clinical Services, Inc.
New York, New York
Behavioral Medical Research of Staten Island
Staten Island, New York
Medark Clinical Trials and Research
Morganton, North Carolina
Richard Weisler, MD and Associates
Raleigh, North Carolina
Wake Research Associates, LLC
Raleigh, North Carolina
Midwest Clinical Research Center
Dayton, Ohio
Pahl Pharmaceutical Research, LLC
Oklahoma City, Oklahoma
Oregon Center for Clinical Investigations, Inc.
Eugene, Oregon
Keystone Clinical Studies, LLC
Norristown, Pennsylvania
CNS Research Institute
Philadelphia, Pennsylvania
Showing 40 of 54 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.